Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, USA,
J Neurooncol. 2013 Nov;115(2):311-6. doi: 10.1007/s11060-013-1222-3. Epub 2013 Aug 16.
For the second time, The Brain Tumor Center of the Weill Cornell Brain and Spine Center, in collaboration with Voices Against Brain Cancer, hosted The Brain Tumor Biotech Summit in New York City in June 2013. After a very successful first summit in 2012, this innovative event has established a platform for intensive networking between neuro-oncologists, neurosurgeons, neuroscientists, members of the biotechnology and pharmaceutical communities, members of the financial community and leaders of non-profit organizations. This year's summit highlighted dendritic cell vaccines, novel antibody, heat shock protein and targeted therapies as well as exosome technologies, MRI-guided therapies and other novel drug delivery tools. This report presents a short overview of the current progress in brain tumor research and therapy as presented at the 2013 Brain Tumor Biotech Summit.
2013 年 6 月，威尔康奈尔脑科中心的脑瘤中心与“反对脑癌之声”合作，第二次在纽约市举办脑瘤生物技术峰会。在 2012 年首次成功举办峰会后，这一创新活动为神经肿瘤学家、神经外科医生、神经科学家、生物技术和制药界成员、金融界成员以及非营利组织的领导人之间建立了一个密集网络的平台。今年的峰会重点介绍了树突细胞疫苗、新型抗体、热休克蛋白和靶向治疗以及外泌体技术、MRI 引导治疗和其他新型药物输送工具。本报告简要概述了 2013 年脑瘤生物技术峰会上展示的脑瘤研究和治疗的最新进展。
